Results 31 to 40 of about 72,947,705 (307)

The use of empirical methods in open source software research: Facts, trends and future directions

open access: yes, 2009
Open Source Software (OSS) is a field of study with increasing interest of researchers. By its nature, OSS is especially suitable for empirical research.
Fitzgerald, B.   +15 more
core   +1 more source

Synthesizing homelessness research: trends, lessons and prospects

open access: yes, 2003
This paper presents an overview of some of the key trends emerging from homelessness research to date, lessons to be learned, and some thoughts on the future prospects for homelessness research.
Anderson, Isobel
core   +1 more source

Early Body Mass Index z‐Score Change and Resolution of Severe Malnutrition in Children With Sickle Cell Anemia in a Low‐Income Setting: A Prospective Single‐Arm Extension Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with sickle cell anemia (SCA) in low‐income settings are at risk of severe malnutrition, but optimal nutritional management has not been established. We evaluated an intensified ready‐to‐use therapeutic food (RUTF) regimen in children with persistent severe malnutrition after initial treatment and assessed whether early ...
Safiya Gambo   +9 more
wiley   +1 more source

Occupying Accountability: Evaluation by Whom and For What?

open access: yes, 2013
Presentation given by Dr Kelly Barr during the Research Trends Virtual Seminar Part 2 - Evaluating Network ...
Research Trends (281463)   +1 more
core   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine   +17 more
wiley   +1 more source

Exploring Research Trends with Rexplore

open access: yesD-Lib Magazine, 2013
Current systems for exploring scholarly data exhibit a number of shortcomings in their ability to facilitate the identification of research trends and identify 'interesting' connections between researchers. To address these issues we have developed Rexplore, a novel system which combines statistics, human-computer interaction, and semantic technologies,
Francesco Osborne, Enrico Motta
openaire   +4 more sources

Uncovering Impact - Moving beyond the journal article and beyond the impact factor

open access: yes, 2013
Presentation given by Dr Heather Piwowar during the Research Trends Virtual Seminar  Part 2 - Evaluating Network ...
Research Trends (281463)   +1 more
core   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Tracking the trends: future directions for human services in Edmonton. Special feature on immigrants.

open access: yes, 1991
\"Tracking the Trends looks at the major social and economic trends likely to influence human services in Edmonton- now and in the near future. The 1991 [3rd] edition has, as its special focus, trends and service implications as they affect Edmonton&
Edmonton Social Planning Council
core   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy